These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 26646037)

  • 1. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
    J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L; Cazard F
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N; Myles H; Clark SR; Bird R; Siskind D
    Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
    Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO
    Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.
    Silva E; Higgins M; Hammer B; Stephenson P
    BMC Psychiatry; 2020 Jun; 20(1):279. PubMed ID: 32503471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine re-challenge under the cover of Filgrastim.
    Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS
    J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony stimulating factor (G-CSF) can allow treatment with clozapine in a patient with severe benign ethnic neutropaenia (BEN): a case report.
    Spencer BW; Williams HR; Gee SH; Whiskey E; Rodrigues JP; Mijovic A; MacCabe JH
    J Psychopharmacol; 2012 Sep; 26(9):1280-2. PubMed ID: 22719015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine-induced neutropenia in children: management with lithium carbonate.
    Sporn A; Gogtay N; Ortiz-Aguayo R; Alfaro C; Tossell J; Lenane M; Gochman P; Rapoport JL
    J Child Adolesc Psychopharmacol; 2003; 13(3):401-4. PubMed ID: 14642024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
    J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
    [No Abstract]   [Full Text] [Related]  

  • 10. Lithium and clozapine rechallenge: a retrospective case analysis.
    Kanaan RA; Kerwin RW
    J Clin Psychiatry; 2006 May; 67(5):756-60. PubMed ID: 16841625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case study; ethnicity and clozapine, a risky combination?].
    Laan WJ; Ramlal D
    Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium and clozapine-induced neutropenia/agranulocytosis.
    Blier P; Slater S; Measham T; Koch M; Wiviott G
    Int Clin Psychopharmacol; 1998 May; 13(3):137-40. PubMed ID: 9690982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
    Lally J; Malik S; Krivoy A; Whiskey E; Taylor DM; Gaughran FP; Flanagan RJ; Mijovic A; MacCabe JH
    J Clin Psychopharmacol; 2017 Oct; 37(5):600-604. PubMed ID: 28817489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
    Béchard L; Corbeil O; Plante M; Thivierge MA; Lafrenière CÉ; Roy MA; Demers MF
    J Psychopharmacol; 2021 Sep; 35(9):1152-1157. PubMed ID: 34229529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
    Kolli V; Denton K; Borra D; Pulluri M; Sharma A
    Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW; Bogers JP; Giltay EJ
    Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy.
    Dunk LR; Annan LJ; Andrews CD
    Br J Psychiatry; 2006 Mar; 188():255-63. PubMed ID: 16507968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine Rechallenge After Neutropenia or Leucopenia.
    Prokopez CR; Armesto AR; Gil Aguer MF; Balda MV; Papale RM; Bignone IM; Daray FM
    J Clin Psychopharmacol; 2016 Aug; 36(4):377-80. PubMed ID: 27232877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I; Bezchlibnyk-Butler K; Wong L
    Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximizing clozapine utilization while minimizing blood dyscrasias: evaluation of patient demographics and severity of events.
    Demler TL; Morabito NE; Meyer CE; Opler L
    Int Clin Psychopharmacol; 2016 Mar; 31(2):76-83. PubMed ID: 26565383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.